Metindaz Forte Use In Pregnancy & Lactation

General advice: Pregnancy category is C.
Women of Childbearing Potential/Birth Control (Contraception): Since the effects of active ingredients in Metronidazole + Miconazole nitrate (METINDAZ FORTE) for fetus and newborn growth are not clearly known, women who must use this product should avoid pregnancy with a proper birth control method.
Pregnancy: The medicinal product is contraindicated in the first trimester of pregnancy. In the second and third trimester of pregnancy, the use of the medicinal product may be possible only when the benefits for the mother are greater than the possible risks for the baby.
Lactation: Breastfeeding should be discontinued since metronidazole appears in milk. Breastfeeding can be started again 24-48 hours after the end of treatment. If the use of the medicinal product is mandatory during the breastfeeding period, the breastfeeding needs to be interrupted, being reinitiated 24-48 hours after the treatment.
Reproduction/Fertility: There is no evidence regarding hazardous effect on human and animal fertility when metronidazole or miconazole nitrate is administered alone.